Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 14, Issue 2

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Drug Safety, Volume 14, Issue 2 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 14, Issue 2 (2015)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Why are anti-obesity drugs stigmatized?

Bruno Halpern MD & Alfredo Halpern MD PhD

Pages: 185-189

Published online: 20 Dec 2014

AbstractforWhy are anti-obesity drugs stigmatized? | Full Text | References | PDF (170.2 KB)

3178 Views
16 CrossRef citations
0Altmetric

Free Access

Original Research

Article

Reporting patterns of adverse drug reactions over recent years in China: analysis from publications

Xiao-jing Guo, Xiao-fei Ye, Xing-xing Wang, Jing Wang, Wen-tao Shi, Qing-bin Gao, Tian-yi Zhang, Jin-fang Xu, Tian-tian Zhu & Jia He (Professor)

Pages: 191-198

Published online: 06 Jan 2015

AbstractforReporting patterns of adverse drug reactions over recent years in China: analysis from publications | Full Text | References | PDF (363.2 KB)

256 Views
16 CrossRef citations
0Altmetric

Article

Brain histamine H₁ receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine

Kotaro Hiraoka, Manabu Tashiro, Thomas Grobosch, Marcus Maurer, Keiichi Oda, Jun Toyohara, Kenji Ishii, Kiichi Ishiwata & Kazuhiko Yanai MD PhD

Pages: 199-206

Published online: 03 Dec 2014

AbstractforBrain histamine H₁ receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine | Full Text | References | PDF (488.2 KB)

1122 Views
26 CrossRef citations
0Altmetric

Review

Potential side effects to GLP-1 agonists: understanding their safety and tolerability

Agostino Consoli (Professor) MD & Gloria Formoso MD PhD

Pages: 207-218

Published online: 12 Dec 2014

AbstractforPotential side effects to GLP-1 agonists: understanding their safety and tolerability | Full Text | References | PDF (303.4 KB)

1127 Views
36 CrossRef citations
0Altmetric

Do antipsychotics increase diabetes risk in children and adolescents?

Britta Galling & Christoph U Correll

Pages: 219-241

Published online: 05 Dec 2014

AbstractforDo antipsychotics increase diabetes risk in children and adolescents? | Full Text | References | PDF (333.3 KB)

635 Views
24 CrossRef citations
0Altmetric

Safety of off-label biologicals in systemic lupus erythematosus

Martin Aringer & Josef S Smolen

Pages: 243-251

Published online: 06 Dec 2014

AbstractforSafety of off-label biologicals in systemic lupus erythematosus | Full Text | References | PDF (244.7 KB)

859 Views
9 CrossRef citations
0Altmetric

Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy

Giuseppe Bronte, Enrico Bronte, Giuseppina Novo, Gianfranco Pernice, Francesca Lo Vullo, Emmanuela Musso, Fabrizio Bronte, Eliana Gulotta, Sergio Rizzo, Christian Rolfo, Nicola Silvestris, Viviana Bazan, Salvatore Novo & Antonio Russo (Professor) MD PhD

Pages: 253-267

Published online: 13 Dec 2014

AbstractforConquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy | Full Text | References | PDF (485.6 KB)

692 Views
40 CrossRef citations
0Altmetric

Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events

Robert MacLaren (Professor) PharmD MPH FCCM FCCP, Lynn E Kassel (Clinical Assistant Professor) PharmD, Tyree H Kiser (Associate Professor) PharmD & Douglas N Fish (Professor) PharmD FCCM FCCP

Pages: 269-280

Published online: 25 Nov 2014

AbstractforProton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events | Full Text | References | PDF (289.4 KB)

718 Views
13 CrossRef citations
0Altmetric

Therapeutic strategies to prevent and manage dyskinesias in Parkinson’s disease

Manuela Pilleri MD & Angelo Antonini MD

Pages: 281-294

Published online: 06 Dec 2014

AbstractforTherapeutic strategies to prevent and manage dyskinesias in Parkinson’s disease | Full Text | References | PDF (472.4 KB)

813 Views
38 CrossRef citations
0Altmetric

Cardiac risks associated with antibiotics: azithromycin and levofloxacin

Zhiqiang Kevin Lu PhD, Jing Yuan BPharm, Minghui Li MS, S Scott Sutton PharmD, Gowtham A Rao PhD, Sony Jacob MD & Charles L Bennett MD PhD MPP

Pages: 295-303

Published online: 10 Dec 2014

AbstractforCardiac risks associated with antibiotics: azithromycin and levofloxacin | Full Text | References | PDF (220.5 KB)

705 Views
54 CrossRef citations
0Altmetric

Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications

Bruno Halpern MD & Alfredo Halpern MD PhD

Pages: 305-315

Published online: 07 Jan 2015

AbstractforSafety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications | Full Text | References | PDF (286.9 KB)

973 Views
24 CrossRef citations
0Altmetric

Drug Safety Evaluation

Umeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelines

James F Davidson (Fellow) MD, James F Donohue (Professor of Medicine) MD & Jill A Ohar (Professor of Medicine) MD

Pages: 317-324

Published online: 17 Jan 2015

AbstractforUmeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelines | Full Text | References | PDF (294.9 KB)

550 Views
0 CrossRef citations
0Altmetric

Drug safety assessment of oral formulations of ketoconazole

Aditya K Gupta MD PhD FRCP(C), Deanne Daigle MSc & Kelly A Foley PhD

Pages: 325-334

Published online: 20 Nov 2014

AbstractforDrug safety assessment of oral formulations of ketoconazole | Full Text | References | PDF (280.5 KB)

528 Views
37 CrossRef citations
0Altmetric

Tigecycline: a critical safety review

Quanhathai Kaewpoowat MD & Luis Ostrosky-Zeichner MD FACP FIDSA FSHEA

Pages: 335-342

Published online: 25 Dec 2014

AbstractforTigecycline: a critical safety review | Full Text | References | PDF (266.7 KB)

1054 Views
64 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

A real-world disproportionality analysis of FDA adverse event reporting system events for ibuprofen

Yikuan Du et al.

Article | Published online: 30 Apr 2024

Signal detection of adverse reactions for bendamustine based on FDA adverse event reporting system

Qing Huang et al.

Article | Published online: 30 Apr 2024

Open Access

Comparison of safety of acetaminophen and ibuprofen in minors: based on the FAERS database

Jing Wang et al.

Article | Published online: 30 Apr 2024

The cardiovascular safety of sodium nitroprusside in acute heart failure

Pier Paolo Bocchino et al.

Editorial | Published online: 29 Apr 2024

Free Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.14, Iss.2, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?